Colon
Upadacitinib tied to fewer colectomies than tofacitinib in ASUC

  • October 16

Colon
Nearly 11,000-patient trial may prompt rethink of 3-year surveillance after adenoma removal

  • October 16

Colon
In pooled trials, cold snare EMR cut adverse events but doubled recurrence

  • October 15

Liver
Dropping age from FIB-4 may simplify MASLD fibrosis screening

  • October 14

Liver

Hepatic encephalopathy tool nearly doubles observer agreement in cirrhosis study

  • October 19

Grades also tracked with ammonia levels and one-year survival, but the authors said multicenter validation is needed before routine clinical use.

BROWSE BY TOPICS

The New Gastroenterologist

Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist

  • August 3

  • by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR

GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.

Esophagus
Bridging the rural divide: Building a motility center in a critical access hospital

  • August 3

  • by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF

“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”

Is professional coaching worth it? A practical guide for early-career gastroenterologists

  • August 3

  • by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG

Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.

The Latest

October 19
Liver
Hepatic encephalopathy tool nearly doubles observer agreement in cirrhosis study

  • by Doug Brunk

Grades also tracked with ammonia levels and one-year survival, but the authors said multicenter validation is needed before routine clinical use.

October 16
Colon
Nearly 11,000-patient trial may prompt rethink of 3-year surveillance after adenoma removal

  • by Julia Cipriano

“More than 99% of the patients in this trial did not receive a diagnosis of colorectal cancer within 5 years after polyp removal.”

October 16
Colon
Upadacitinib tied to fewer colectomies than tofacitinib in ASUC

  • by Doug Brunk

By week 52, 23% of patients given upadacitinib vs. 43% given tofacitinib had undergone colectomy in a retrospective study of 150 Australian adults.

October 15
Colon
In pooled trials, cold snare EMR cut adverse events but doubled recurrence

  • by Meg Barbor

“Current evidence excludes cold EMR as an adequate technique for advanced adenomas,” the authors wrote.

October 14
Liver
Dropping age from FIB-4 may simplify MASLD fibrosis screening

  • by Julia Cipriano

Across 938 patients, five age-handling strategies had similar discrimination for fibrosis but traded off sensitivity and specificity differently, investigators reported.